Pasadena, CA, United States of America

Stephen B Kent


Average Co-Inventor Count = 2.8

ph-index = 10

Forward Citations = 317(Granted Patents)


Company Filing History:


Years Active: 1987-1997

Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stephen B. Kent in Hepatitis B Research

Introduction

Stephen B. Kent, based in Pasadena, CA, is a prominent inventor known for his significant contributions to medical science, particularly in the field of hepatitis B research. With a total of 11 patents to his name, Kent has developed innovative solutions that have the potential to improve disease diagnostics and vaccine development.

Latest Patents

Among his latest innovations are patents focused on assays for detecting hepatitis B virus envelope antigens or antibodies. His hepatitis B vaccine involves a peptide with an amino acid chain of at least six consecutive amino acids within the pre-S gene coded region of the virus's envelope. This novel vaccine is designed to be free from sequences that correspond to the naturally occurring envelope proteins of the virus and includes a physiologically acceptable diluent. The peptide can be unbound or linked to a carrier, which can be a conventional or a novel carrier—such as a lipid vesicle stabilized by cross-linking. This innovative carrier not only facilitates the linkage of the peptide but also serves to bind synthetic peptide analogues of other viral proteins, as well as bacterial, allergen, and parasitic proteins from humans and animals. The peptides produced in this invention can be effectively utilized in diagnostics for detection purposes concerning antigens and antibodies.

Career Highlights

Stephen B. Kent has made substantial strides in his career, working with notable institutions such as the California Institute of Technology and the New York Blood Center, Inc. His work at these renowned establishments has allowed him to innovate and expand the boundaries of hepatitis B treatment and diagnosis.

Collaborations

Throughout his career, Kent has collaborated with distinguished colleagues, including Alexander Robert Neurath and John A. Bridgham. These partnerships have fostered an environment of creativity and shared expertise, contributing to the advancement of the field.

Conclusion

Stephen B. Kent's innovative research and patent developments mark him as a key figure in the fight against hepatitis B. His commitment to improving vaccine technology and diagnostic methods highlights the important role of inventors in the medical field, paving the way for better health outcomes worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…